Establishment Labs Holdings Inc. (ESTA)
NASDAQ: ESTA · IEX Real-Time Price · USD
42.75
-0.59 (-1.36%)
At close: Jul 2, 2024, 4:00 PM
42.50
-0.25 (-0.58%)
After-hours: Jul 2, 2024, 5:27 PM EDT
ESTA Revenue
Establishment Labs Holdings had revenue of $155.79M in the twelve months ending March 31, 2024, down -8.23% year-over-year. Revenue in the quarter ending March 31, 2024 was $37.17M, a -20.11% decrease year-over-year. In the year 2023, Establishment Labs Holdings had annual revenue of $165.15M with 2.13% growth.
Revenue (ttm)
$155.79M
Revenue Growth
-8.23%
P/S Ratio
7.55
Revenue / Employee
$171,579
Employees
908
Market Cap
1.18B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 165.15M | 3.45M | 2.13% |
Dec 31, 2022 | 161.70M | 35.02M | 27.64% |
Dec 31, 2021 | 126.68M | 42.01M | 49.61% |
Dec 31, 2020 | 84.68M | -4.89M | -5.46% |
Dec 31, 2019 | 89.57M | 28.36M | 46.33% |
Dec 31, 2018 | 61.21M | 26.53M | 76.49% |
Dec 31, 2017 | 34.68M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AdaptHealth | 3.25B |
Brookdale Senior Living | 3.05B |
Omnicell | 1.10B |
Pacira BioSciences | 681.75M |
Phreesia | 373.67M |
BioCryst Pharmaceuticals | 355.40M |
Kiniksa Pharmaceuticals | 301.77M |
Vir Biotechnology | 79.60M |
ESTA News
- 5 weeks ago - Establishment Labs Announces Participation in Two Upcoming Investment Conferences - Business Wire
- 7 weeks ago - Establishment Labs Reports First Quarter 2024 Financial Results - Business Wire
- 2 months ago - Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024 - Business Wire
- 2 months ago - Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America - Business Wire
- 2 months ago - Establishment Labs to Announce First Quarter 2024 Financial Results on May 8 - Business Wire
- 2 months ago - Establishment Labs Announces Participation in The Aesthetic Meeting 2024 - Business Wire
- 4 months ago - Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance - Business Wire
- 4 months ago - Establishment Labs Announces Amended Credit Facility with Oaktree - Business Wire